Physician profile
David Cameron
NPI 1538422423
$10,146.06
in general payments reported to CMS, 2019-2025
20 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $146 · 2021: $1,038 · 2022: $4,249 · 2023: $2,623 · 2024: $949 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,339 · Travel and Lodging: $1,374 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,338.97 |
| Travel and Lodging | $1,374.10 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,367.91 | 2021-2024 | Da Vinci Surgical System, Davinci Xi |
| Hologic Sales and Service, LLC | $1,032.96 | 2024-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $408.88 | 2022-2025 | |
| Coopersurgical, INC. | $230.71 | 2020-2025 | Ally II Ups |
| Conmed Corporation | $208.92 | 2022-2024 | Airseal |
| Ethicon US, LLC | $201.93 | 2025 | Stratafix, Dermabond Prineo |
| Pacira Pharmaceuticals Incorporated | $124.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.26 | 2022-2025 | |
| Astellas Pharma US INC | $91.19 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $61.39 | 2022-2025 | Slynd |
| Abbvie INC. | $58.87 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Meditrina | $55.73 | 2023-2025 | |
| Agile Therapeutics, INC. | $36.41 | 2023-2024 | Twirla |
| Channel Medsystems, INC. | $32.07 | 2022 | |
| Medtronic, INC. | $30.50 | 2022-2025 | V-Loc 180 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $27.99 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $25.53 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $23.97 | 2024 | |
| Pfizer INC. | $18.14 | 2024 | |
| Therapeuticsmd, INC. | $12.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.